Jeuveau (prabotulinumtoxinA-xvfs) – For the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients.
JEUVEAU DOSAGE AND ADMINISTRATION
Glabellar Lines Administration: 0.1 mL (4 Units) by intramuscular injection into each of five sites, for a total dose of 20 Units (2.2, 2.3)
JEUVEAU INDICATIONS AND USAGE
JEUVEAU is an acetylcholine release inhibitor and a neuromuscular blocking agent indicated for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients (1)
JEUVEAU ADVERSE REACTIONS
JEUVEAU can cause Headache , Eyelid Ptosis, Upper Respiratory Tract Infection, Increase White Blood Cell count.
JEUVEAU DRUG INTERACTIONS
Patients receiving concomitant treatment of JEUVEAU and aminoglycosides or other agents interfering with neuromuscular transmission (e.g. curare-like agents), or muscle relaxants, should be observed closely because the effect of JEUVEAU may be potentiated (7).
<<BACK